Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Washington State offers a wide range of paid volunteering opportunities for both healthy participants and those looking for condition-specific clinical studies. Key centers in Seattle, Spokane, and Tacoma are actively recruiting participants, providing access to advanced medical treatments and innovative care solutions.
Filter
1
Filter results
Results: 1,593
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: Boston MA, New York NY, St Louis MO, Seattle WA,
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06745076
Phase2, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: Durham NC, Roanoke VA, Orange City FL, Fort Myers FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase3, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase2, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
for
HER2-positive Advanced Solid Tumor
Location: Boston MA, Shirley NY, Lake Success NY, New York NY,